Skip to main content
Medical Reference · Condition Monograph

Hepatitis A

A형 간염

Hepatitis A has long been recognized as "contagious jaundice."

History

Hepatitis A has long been recognized as "contagious jaundice." It was known from experience as a disease that young children in areas with poor sanitation contracted relatively commonly and from which they recovered naturally over time. Medically, as it came to be classified as one form of "viral infection causing acute inflammation of the liver," a concept distinguishing it from other hepatitis viruses was established. In particular, unlike hepatitis B and C, which progress chronically through the blood, the fact that hepatitis A usually ends as an acute illness and has no chronic carrier state became established as its key feature.

In the 1970s, as the hepatitis A virus was identified and it became possible to distinguish acute infection with blood tests, diagnosis became much clearer. Whereas before, it had been lumped together roughly as "hepatitis when liver enzyme levels rise and jaundice appears," it became possible to distinguish "whether it is currently hepatitis A" and "whether there is immunity from past infection or vaccination."

The biggest turning point was the advent of vaccination. After the inactivated vaccine was introduced, the number of patients decreased greatly in some countries as childhood vaccination policies and vaccination of high-risk groups were expanded. Recent research summarizes that outbreaks can recur even in low-endemicity areas through travel, sanitation problems among vulnerable urban populations, and certain sexual behavior networks.

Causes

The cause of hepatitis A is infection with the hepatitis A virus. This virus is mainly transmitted by the fecal-oral route. That is, infection begins when virus from an infected person's feces enters the mouth via the hands, or when contaminated water or food enters the mouth. Because of this characteristic, personal hygiene, food hygiene, and a safe water supply are the most important lines of defense.

The situations in which infection commonly occurs can be summarized into three broad categories. First, transmission through person-to-person contact in environments where handwashing or toilet hygiene is inadequate. Second, infection from eating food washed in contaminated water or prepared in a contaminated environment, or raw or undercooked seafood such as shellfish grown in contaminated waters. Third, transmission through sexual contact, particularly contact involving the mouth and the anal area.

In hepatitis A, the infection itself is the cause. However, people with preexisting chronic liver disease, people with weakened immunity, and older adults may become more seriously ill from the same infection. Recent research points out that when adult infections increase in areas where sanitation has generally improved, the burden of hospitalization and mortality can grow.

Genetic Epidemiology

For hepatitis A, it is natural to understand "genetic epidemiology" in two layers. One is the genetic diversity of the virus itself, and the other is the area concerning the extent to which a person's constitution influences the severity of the disease. On the virus side, the hepatitis A virus is known to have a single serotype, so once immunity is established, reinfection almost never occurs for life. However, several genotypes exist. The distribution of these genotypes can differ by region and outbreak group, and they are used to trace, when an outbreak occurs, "whether it is the same outbreak or a new introduction from elsewhere."

Regarding human genetic predisposition, because hepatitis A is an acute infection from which most people recover naturally, it is difficult to summarize with a simple conclusion. However, since the immune response is a major cause of liver damage, the possibility that individual differences in immune response partly influence the clinical course has been studied consistently.

Recent research summarizes that genetic analysis is becoming increasingly important for revealing the links in an outbreak and confirming foodborne infection or transmission within particular networks. From the general public's point of view, it is enough to understand that "age, the presence of preexisting liver disease, immune status, and the amount of exposure" are bigger factors determining severity than genetics.

General Epidemiology

The prevalence of hepatitis A is greatly influenced by "the level of sanitation" and "vaccination policy." In areas with very poor sanitation, most people are infected in childhood and become immune before adulthood, so large-scale outbreaks in adults are in some cases actually less noticeable. Conversely, in areas where sanitation has improved, childhood infections decrease and the number of non-immune adolescents and adults increases, and when outbreaks occur in this group, symptoms are more severe and hospitalizations increase, which can raise the burden on society.

Recent research reports that although the incidence of hepatitis A worldwide shows a long-term downward trend, disparities between countries remain large and incidence differs greatly according to socioeconomic level. Outbreaks mainly appear in the form of cluster outbreaks. Foodborne outbreaks, person-to-person transmission outbreaks, and sexual contact network outbreaks are representative.

A characteristic of hepatitis A is that "many children are asymptomatic but can still transmit the virus." For this reason, it is difficult to fully grasp the actual scale of infection from the number of visible patients alone, and serology-based immunity surveys and surveillance systems are also needed. Recent research summarizes that urban outbreaks can drag on for a long time as person-to-person transmission persists among vulnerable adult groups.

Pathogenesis

Hepatitis A begins as the virus multiplies in liver cells, but much of the actual liver damage is produced by the body's own immune response. After infection, the virus enters through the mouth, moves through the intestine into the bloodstream, reaches the liver, and multiplies in the liver cells and the liver's immune cells. In this process, rather than the virus itself strongly destroying the cells, inflammation and liver cell damage arise as the immune response that tries to eliminate infected cells is activated.

The incubation period is generally known to be about 2 to 6 weeks. Large amounts of the virus can be shed in the feces even before symptoms appear, so it is possible for a person to spread it to those around them during a period when they do not know they are ill. This is one of the reasons cluster outbreaks occur easily.

After infection, immunity is established, reinfection almost never occurs, and the infection does not lead to chronic infection. However, in some people, a "relapsing course," in which symptoms reappear even after recovery, has been reported. Also, it can rarely progress to acute liver failure, and this risk is greater in older people or those with preexisting liver disease. Recent research emphasizes that greater vigilance for severe complications is needed in immunocompromised patients and patients with underlying liver disease.

Symptoms

The symptoms of hepatitis A differ greatly by age. In children, it is common for infection to cause almost no symptoms or to pass like a cold. In adults, on the other hand, relatively typical symptoms of acute hepatitis are more likely to appear. Common symptoms are systemic symptoms such as fatigue, loss of appetite, nausea, vomiting, diarrhea, low-grade fever, and muscle aches. After that, the urine may become dark, the stool may become pale, and jaundice, in which the skin and eyes turn yellow, may appear.

In most cases, symptoms improve within a few weeks, but recovery can take several months. In some people, a relapsing course, in which symptoms disappear and then reappear, is known to occur within 6 months.

Although rare, it can progress to acute liver failure in older adults or people with underlying liver disease, so emergency evaluation is needed if changes in consciousness, a severe bleeding tendency, or extreme jaundice appear.

Signs

The signs confirmed on examination and testing follow the typical pattern of acute hepatitis. Physically, jaundice is the most noticeable finding. The skin and sclera turn yellow, and darkening of the urine is observed along with it. The liver may be slightly enlarged or tender, but hepatitis A cannot be confirmed by abdominal examination alone.

On blood tests, it is common for liver enzymes, which reflect liver cell damage, to rise markedly. When bilirubin rises, jaundice becomes more severe, and when coagulation values worsen, the risk of acute liver failure should be suspected. In the acute phase, changes in blood cell counts may accompany the systemic inflammatory response.

A characteristic sign of hepatitis A is that "antibodies suggesting acute infection are detected in the blood." Because the pattern in which these antibodies appear differs depending on the timing of infection, they are key to distinguishing whether there is currently an acute infection or whether immunity has developed from past infection or vaccination.

Screening

Because hepatitis A often causes asymptomatic infection and most people recover naturally, large-scale screening of the general population is realistically of low efficiency. Instead, the key to screening is to develop vaccination and post-exposure management strategies centered on "people at high risk of infection, or at high risk of severe illness if infected."

The starting point of screening is an assessment of risk situations. This includes checking whether the person plans to travel to an area where hepatitis A is endemic, whether they live or work in an environment with inadequate sanitation, whether they are associated with homelessness or group living (facilities, incarceration, etc.), whether there is drug use, and whether there are particular sexual contact behaviors. If these risks are high, vaccination status can be checked and, if necessary, immune status (whether antibodies are present) can be tested to plan a vaccination strategy.

People with preexisting chronic liver disease may face an increased risk of complications if they contract hepatitis A, so they are an important target of "high-risk group screening." Recent research suggests that in areas or groups where outbreaks recur, expanding vaccination of high-risk adults is important for controlling outbreaks.

Diagnosis

The diagnosis of hepatitis A is confirmed by combining clinical symptoms with blood tests. This is because it is difficult to distinguish it from other forms of acute hepatitis (e.g., hepatitis B, hepatitis C, drug-induced hepatitis, etc.) based on symptoms alone. The most essential test is to identify, in the blood, "antibodies indicating acute infection." In the acute phase, a specific immunoglobulin antibody is detected, and in the recovery phase, antibodies reflecting long-term immunity remain. This pattern is used to distinguish whether there is a current infection or immunity from past infection or vaccination.

Basic liver function tests such as liver enzymes, bilirubin, coagulation values, and albumin are important for assessing severity. To judge the risk of acute liver failure, mental status, blood glucose, and worsening coagulation values are examined together. Imaging is not a required test for confirming hepatitis A. However, it can be used to rule out other causes such as gallstones or biliary obstruction, or for differential diagnosis when there is severe abdominal pain.

In cluster outbreak situations, viral genotype analysis is sometimes used to confirm patient-to-patient transmission links or to trace foodborne sources of infection. Recent research summarizes that such molecular epidemiological tools are becoming increasingly useful in responding to outbreaks.

Treatment

Treatment of hepatitis A is mostly centered on supportive care. That is, it is an approach of relieving symptoms and monitoring for complications while the body eliminates the virus. It is important to maintain adequate fluids and nutrition and, if vomiting or diarrhea is severe, to prevent dehydration. Rest is needed during periods of severe fatigue. It is safer to avoid drugs that may burden the liver. In particular, caution is needed because fever reducers and pain relievers metabolized by the liver, dietary supplements, and herbal medicine or folk remedies can worsen liver damage.

Most people recover completely, but hospital observation may be needed if there is dehydration, severe jaundice, a bleeding tendency, or changes in consciousness, or in cases of older age, underlying liver disease, or an immunocompromised state. In rare cases where acute liver failure occurs, liver transplantation can be a life-saving treatment.

As a treatment in terms of prevention, there is "post-exposure prophylaxis." When a person has had close contact with an infected person, vaccination within a certain period can prevent the illness or lessen its course. Recent research has presented evidence that a strategy of administering the inactivated vaccine within a certain period after exposure can be effective.

Prognosis

The prognosis of hepatitis A is usually good. It is characterized by not leading to chronic liver disease and by lifelong immunity forming after one has had it once. Therefore, most patients recover completely within a few weeks to a few months. However, the prognosis is not always mild. In adults, especially older adults, symptoms are more severe and the likelihood of hospitalization is higher. In addition, for people with preexisting chronic liver disease, hepatitis A can be an "additional blow," increasing the risk of acute liver failure.

A relapsing course (a form in which symptoms disappear and then reappear) may occur in some people. Even in this case, people usually recover in the long term, but patients may experience fatigue and reduced work and daily functioning for a long period, so explanation and management are needed.

The practical factors that determine prognosis are age, the presence of underlying liver disease, immune status, and the presence or absence of complications in the acute phase (especially worsening coagulation values and changes in consciousness). Recent research reports that hospitalization rates can be substantial in foodborne outbreaks and that the burden of complications can be greater in older populations.

Prevention

Prevention can be summarized in two pillars: first, vaccination, and second, hygiene management. Vaccination is the most effective method of preventing hepatitis A. In countries that implement national childhood immunization, incidence decreases greatly. For adults, priority vaccination is considered for travelers to endemic areas, people with chronic liver disease, immunocompromised people, certain occupational groups, and groups at risk due to certain sexual behaviors. Recent research suggests that because susceptible adult populations increase in societies where natural immunity has declined owing to improved sanitation, a vaccination strategy for high-risk adults may become more important in situations where outbreaks recur.

The key to hygiene management is handwashing. Washing hands thoroughly with soap after using the toilet, after changing diapers, before and after cooking, and before eating greatly reduces transmission. It is safer to eat food that is thoroughly cooked and, in particular, to avoid eating shellfish raw. When traveling, drink safe water and be careful with foods that may be contaminated, such as ice or raw vegetables.

Post-exposure prophylaxis is also an important part of prevention. When a case occurs in a family member or close contact, administering vaccination (or, in some cases, immunoglobulin) within a certain period can reduce secondary infections. Recent research summarizes that such post-exposure strategies can make a substantial contribution to controlling outbreaks.

This content is provided for general medical information only and does not replace individual diagnosis or treatment. If symptoms persist, please consult a medical professional.